CARLSBAD, Calif. (AP) _ Ionis Pharmaceuticals Inc. (IONS) on Wednesday reported a loss of $65 million in its first quarter.On a per-share basis, the Carlsbad, California-based company said it had a loss of 46 cents.The results topped Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 68 cents per share.The drug discovery and development company posted revenue of $142 million in the period, which also beat Street forecasts. Eight analysts surveyed by Zacks expected $129.2 million._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IONS at https://www.zacks.com/ap/IONS